Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2003-05-28
2008-07-29
Mondesi, Robert B. (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S350000
Reexamination Certificate
active
07405202
ABSTRACT:
Included in the present invention are methods of inhibiting sperm capacitation, inhibiting the phosphorylation of a protein at tyrosine residues, inhibiting an acrosomal reaction, and inhibiting fertilization of an egg by sperm with the administration of a CRISP polypeptide.
REFERENCES:
patent: 5250417 (1993-10-01), Feuchter et al.
patent: 5565197 (1996-10-01), Allen
patent: 5569581 (1996-10-01), Killian et al.
patent: 5660997 (1997-08-01), Spaulding
patent: 5707829 (1998-01-01), Jacobs et al.
patent: 5718896 (1998-02-01), Allen
patent: 5723305 (1998-03-01), Sullivan et al.
patent: 5756681 (1998-05-01), Neurath et al.
patent: 5851817 (1998-12-01), Hardy et al.
patent: 5910568 (1999-06-01), Hammerstedt et al.
patent: 5969093 (1999-10-01), Jacobs et al.
patent: 5989549 (1999-11-01), Sullivan et al.
patent: 6011013 (2000-01-01), Carr et al.
patent: 6045786 (2000-04-01), Cone et al.
patent: 6051603 (2000-04-01), D'Cruz et al.
patent: 6083940 (2000-07-01), Tanabe et al.
patent: 6159934 (2000-12-01), Pescovitz
patent: 6166178 (2000-12-01), Cech et al.
patent: 6177475 (2001-01-01), Tatarintsev et al.
patent: 6180682 (2001-01-01), Place
patent: 6191120 (2001-02-01), D'Cruz et al.
patent: 6197940 (2001-03-01), Klinefelter
patent: 6231862 (2001-05-01), Majunder et al.
patent: 6235708 (2001-05-01), Holloway et al.
patent: 6245529 (2001-06-01), Holloway et al.
patent: 6251671 (2001-06-01), Hogan et al.
patent: 6258364 (2001-07-01), Herr et al.
patent: 6306823 (2001-10-01), Majumder et al.
patent: 6319947 (2001-11-01), D'Cruz et al.
patent: 6337348 (2002-01-01), Uckun et al.
patent: 6344442 (2002-02-01), Habenicht et al.
patent: 6350736 (2002-02-01), Uckun et al.
patent: 6355235 (2002-03-01), Cone et al.
patent: 2002/0004479 (2002-01-01), Habenicht et al.
patent: 2002/0058309 (2002-05-01), Baker et al.
patent: 2002/0164368 (2002-11-01), Zimmerman
patent: 1006125 (2000-06-01), None
patent: 974910 (1964-11-01), None
patent: 11279197 (1999-10-01), None
patent: 97 27218 (1997-07-01), None
patent: 99 54354 (1999-10-01), None
patent: 99 57267 (1999-11-01), None
patent: 0031264 (2000-06-01), None
patent: 01/31343 (2001-05-01), None
patent: 01/66747 (2001-09-01), None
patent: 0200001 (2002-01-01), None
patent: 02 14348 (2002-02-01), None
patent: 03100025 (2003-12-01), None
Schwidetzky et al., “Isolation and characterization of the androgen-dependent mouse cysteine-rich secretory protein-3 (Crisp-3) gene”, Biochem. J. 309: 831-836 (1995).
Martinez et al., “Potential contraceptive use of epididymal proteins: evidence for the participation of specific antibodies against rat epididymal protein DE in male and female fertility inhibition”, Journal of Reproductive Immunology 29: 31-45 (1995).
Nixon et al., “The identification of mouse sperm-surface-associated proteins and characterization of their ability to act as decapacitation factors”, Biology of Reproduction 74: 275-287 (2006).
Aonumo et al., “Studies on Sperm Capacitation. Characterization of Decapacitation Factor from Guinea-pig Spermatozoa,”Chem Pharm Bull(Tokyo) 1976, 24:907-911.
Austin, “Observations on the Penetration of the Sperm into the Mammalian Egg,”Australian Journal of Scientific Research, B 1951, 4:581-589.
Bedford, “Sperm Capacitation and Fertilization in Mammals,”Biol Reprod1970, 2:Supp 2:128-158.
Bendahmane et al., “Assessment of acrosomal status in rat spermatoza: studies on carbohydrate and non-carbohydrate agonists,”Arch Biochem Biophys2002, 404:38-47.
Biggers et al., “The Culture of Mouse Embryos in Vitro,”Methods in Mammalian Embryology1971, 86-116.
Bligh et al., “A Rapid Method of Total Lipid Extraction and Purification,”Canadian Journal of Biochemistry and Physiology1959, 37:911-917.
Boue et al., “Surface Localization of P34H, an Epididymal Protein, during Maturation, Capacitation, and Acrosome Reaction of Human Spermatozoa,”Biol Reprod1996, 54:1009-1017.
Brietbart, “Intracellular calcium regulation in sperm capacitation and acrosomal reaction,”Mol Cell Endocrinol2002, 187:139-144.
Brooks et al., “Molecular cloning of the cDNA for androgen-dependent sperm-coating glycoproteins secreted by the rat epididymis,”Eur. J. Biochem1986, 161(1):13-18.
Brooks et al., “Characterization and androgen-dependence of proteins associated with luminal fluid and spermatozoa in the rat epididymis,”Journal of Reproduction&Fertility1980, 59:363-375.
Brooks et al., “Localization of epididymal secretory proteins on rat spermatozoa,”Journal of Reproduction&Fertility1983, 69:651-657.
Cameo et al., “Androgen-Controlled Specific Proteins in Rat Epididymis,”Journal of Endocrinology1976, 69:47-55.
Chang, “Fertilizing Capacity of Spermatozoa deposited into the Fallopian Tubes,”Nature1951, 168:697-698.
Charest et al., “Molecular Cloning of Complementary Deoxyribonucleic Acid for an Androgen-Regulated Epididymal Protein: Sequence Homology with Metalloproteins,”Mol. Endocrinol. 1988, 2(10):999-1004.
Choi et al., “Cyclodextrin Removes Cholesterol from Mouse Sperm and Induces Capactitation in a Protein-Free Medium,”Biol Reprod1998, 59:1328-1333.
Cohen et al., “Mammalian sperm-egg fusion: the development of rat oolemma fusibility during oogenesis involves the appearance of binding sites for sperm protein “DE”,”Biol Reprod., Jul. 1996, 55(1):202-206.
Cohen et al., “Relationship between the association of rat epididymal protein “DE” with spermatozoa and the behavior and function of the protein”,Molecular Reproduction and Development, 2000, 56:180-188.
Cohen et al., “Mammalian sperm-egg fusion: evidence that epididymal protein DE plays a role in mouse gamete fusion”,Biol Reprod., Aug. 2000, 63(2):462-468.
Cohen et al., “Evidence that human epididymal protein ARP plays a role in gamete fusion through complementary sites on the surface of the human egg”,Biol Reprod., Oct. 2001, 65(4):1000-1005.
Cuasnicu et al., “Antibodies against epididymal glycoproteins block fertilizing ability in rat”,Journal of Reproduction&Fertility, 1984, 72:467-471.
Cuasnicu et al., “Molecular Mechanisms Involved in Mammalian Gamete Fusion”,Arch Med Res, Nov.-Dec. 2001, 32(6):614-618.
Davis. “Timing of fertilization in mammals: Sperm cholesterol/ phospholipid ratio as a determinant of the capacitation interval,”Proc Natl Acad Sci USA. 1981, 78:7560-7564.
Davis, “Influence of Serum Albumin on the Fertilizing Ability In Vitro of Rat Spermatozoa (39182),”Proc Soc Exp Biol Med1976, 151:240-243.
Davis et al., “Studies on the mechanism of capacitation: Albumin-mediated changes in plasma membrane lipids during in vitro incubation of rat sperm cells,”Proc Natl Acad Sci USA.1980, 77:1546-1550.
Dorval et al., “Regulation of the Phosphotyrosine Content of Human Sperm Proteins by Intracellular Ca2+: Role of CA2+-Adenosine Triphosphatases,”Biol Reprod2002, 67:1538-1545.
Eberspaecher et al., “Mouse androgen-dependent epididymal glycoprotein CRISP-1 (DE, AEG): isolation, biochemical characterization, and expression in recombinant form”,Mol. Reprod. Dev. 1995, 42:157-172.
Ellerman et al., “Potential contraceptive use of epididymal proteins: immunization of male rats with epididymal protein DE inhibits sperm fusion ability”,Biol Reprod., 1998, 59:1029-1036.
Eng et al., “Rabbit Sperm Reversible Decapacitation by Membrane Stabilization with a Highly Purified Glycoprotein from Seminal Plasma,”Biol Reprod1978, 19:1083-1094.
Evans, “Sperm disintegrins, egg integrins, and other cell adhesion molecules of mammalian gamete plasma membrane interactions”,Front in Biosci, Jan. 15, 1999;4:d114-131.
Evans, “The molecular basis of sperm-oocyte membrane interactions during mammalian fertilization”Human Reproduction Update, 2002
Ensrud Kathy M.
Hamilton David W.
Roberts Kenneth P.
Desai Anand U
Mondesi Robert B.
Mueting Raasch & Gebhardt, P.A.
Regents of the University of Minnesota
LandOfFree
CRISP polypeptides as contraceptives and inhibitors of sperm... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with CRISP polypeptides as contraceptives and inhibitors of sperm..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CRISP polypeptides as contraceptives and inhibitors of sperm... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3965795